Customize your search results with filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 02/19/2023

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 289 publications

Chemo-Immunotherapy in First Line Extensive Stage Small Cell Lung Cancer (ES-SCLC): A Systematic Review and Meta-Analysis.

Condition: Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Journal: Current oncology (Toronto, Ont.)
Treatment Used: Chemo-Immunotherapy
Number of Patients: 0
Published: December 22, 2022

Combining PD-1 or PD-L1 inhibitors with chemotherapy is a good strategy for the treatment of extensive small cell lung cancer: A retrospective analysis of clinical studies.

Condition: Extensive-Stage Small-Cell Lung Cancer (ES-SCLC)
Journal: Frontiers in immunology
Treatment Used: Combining Programmed Cell Death (PD-1) or Programmed Cell Death Ligand 1 (PD-L1) Inhibitors with Chemotherapy vs. Chemotherapy Alone
Number of Patients: 2600
Published: December 22, 2022

A Case of Second Primary Small Cell Lung Carcinoma after Radiotherapy for Breast Cancer.

Condition: Second Primary Small Cell Lung Carcinoma After Breast Cancer
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Treatment Used: Chemotherapy
Number of Patients: 1
Published: December 20, 2022

Efficacy and safety of immune checkpoint inhibitors plus anlotinib in small cell lung cancer with brain metastases: a retrospective, multicentre study.

Condition: Small Cell Lung Cancer (SCLC) with Brain Metastases (BM)
Journal: Journal of neuro-oncology
Treatment Used: Immune Checkpoint Inhibitors (ICIs) with Anlotinib
Number of Patients: 66
Published: November 08, 2022

Thoracic radiotherapy may improve the outcome of extensive stage small cell lung carcinoma patients treated with first-line immunotherapy plus chemotherapy.

Condition: Extensive Stage Small Cell Lung Carcinoma (ES-SCLC)
Journal: Anti-cancer drugs
Treatment Used: Thoracic Radiotherapy
Number of Patients: 22
Published: October 07, 2022

Efficacy and Safety of Paclitaxel/nab-paclitaxel Chemotherapy for Patients With Relapsed Small Cell Lung Cancer.

Condition: Relapsed Small Cell Lung Cancer (SCLC)
Journal: Anticancer research
Treatment Used: Paclitaxel/Nab-Paclitaxel Chemotherapy
Number of Patients: 31
Published: October 03, 2022

Prophylactic cranial irradiation (PCI) versus active surveillance in patients with limited-stage small cell lung cancer: a retrospective, multicentre study.

Condition: Limited-Stage Small Cell Lung Cancer (LS-SCLC)
Journal: Respiratory research
Treatment Used: Prophylactic Cranial Irradiation (PCI)
Number of Patients: 1068
Published: October 02, 2022

Immune checkpoint inhibitor therapy in a patient with small cell lung cancer and anti-transcriptional intermediary factor 1-γ antibody-positive dermatomyositis: A case report.

Condition: Small Cell Lung Cancer and Dermatomyositis
Journal: Thoracic cancer
Treatment Used: Immune Checkpoint Inhibitor (ICI) Therapy
Number of Patients: 1
Published: August 19, 2022

A 75-Year-Old Female Smoker with Advanced Small-Cell Lung Cancer and Eastern Cooperative Oncology Group Performance Status 2 who Responded to Combination Immunochemotherapy with Atezolizumab, Etoposide, and Carboplatin.

Condition: Advanced Small-Cell Lung Cancer
Journal: The American journal of case reports
Treatment Used: Combination Immunochemotherapy with Atezolizumab, Etoposide, and Carboplatin
Number of Patients: 1
Published: August 11, 2022

Small cell lung cancer-Established standards and new approaches.

Condition: Small Cell Lung Cancer (SCLC)
Journal: Innere Medizin (Heidelberg, Germany)
Treatment Used: Immunochemotherapy
Number of Patients: 0
Published: August 04, 2022

Olaparib as maintenance treatment in patients with chemosensitive small cell lung cancer (STOMP): A randomised, double-blind, placebo-controlled phase II trial.

Condition: Small Cell Lung Cancer (SCLC)
Journal: Lung cancer (Amsterdam, Netherlands)
Treatment Used: Olaparib
Number of Patients: 220
Published: July 25, 2022

Small Cell Lung Cancer in the Course of Idiopathic Pulmonary Fibrosis-Case Report and Literature Review.

Condition: Small Cell Lung Cancer in Patient with Idiopathic Pulmonary Fibrosis (IPF)
Journal: Current oncology (Toronto, Ont.)
Treatment Used: Chemotherapy
Number of Patients: 1
Published: July 25, 2022
Showing 1-12 of 289

Last Updated: 02/19/2023